TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel SarcopeniaFrailty Treatment at Prestigious International Conference
TNFA Stock | 1.27 0.09 6.62% |
About 61% of TNF Pharmaceuticals,'s investor base is looking to short. The analysis of overall sentiment of trading TNF Pharmaceuticals, stock suggests that many investors are alarmed at this time. The current market sentiment, together with TNF Pharmaceuticals,'s historical and current headlines, can help investors time the market. In addition, many technical investors use TNF Pharmaceuticals, stock news signals to limit their universe of possible portfolio assets.
TNF |
BALTIMORE, December 09, 2024--TNF Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company committed to developing novel oral therapies for autoimmune and inflammatory conditions, today announced that significant positive topline results from a Phase 2a study of its lead drug candidate MYMD-1 was presented at a prestigious international congress of global experts in sarcopenia and related disorders held December 68, 2024 in Washi
Read at finance.yahoo.com
TNF Pharmaceuticals, Fundamental Analysis
We analyze TNF Pharmaceuticals,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TNF Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TNF Pharmaceuticals, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
TNF Pharmaceuticals, is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
TNF Pharmaceuticals, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with TNF Pharmaceuticals, stock to make a market-neutral strategy. Peer analysis of TNF Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing TNF Pharmaceuticals, by comparing valuation metrics with similar companies.
Peers
TNF Pharmaceuticals, Related Equities
MS | Morgan Stanley | 2.93 | ||||
SHAK | Shake Shack | 2.45 | ||||
FRHC | Freedom Holding | 1.48 | ||||
BYD | Boyd Gaming | 0.67 | ||||
CBTN | Citizens Bancorp | 0.00 | ||||
RAND | Rand Capital | 0.00 | ||||
WEN | Wendys | 0.12 | ||||
BHM | Bluerock Homes | 0.67 |
Complementary Tools for TNF Stock analysis
When running TNF Pharmaceuticals,'s price analysis, check to measure TNF Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TNF Pharmaceuticals, is operating at the current time. Most of TNF Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of TNF Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TNF Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of TNF Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |